Do not stop or change your medication without speaking to a pharmacist or healthcare professional.

This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →

Shortage Avoided

DEFEROXAMINE MESYLATE FOR INJECTION

PFIZER CANADA ULC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of DEFEROXAMINE MESYLATE FOR INJECTION in Canada?

Yes. DEFEROXAMINE MESYLATE FOR INJECTION 2G has an active shortage reported to Health Canada (last updated November 5, 2026).

Why is DEFEROXAMINE MESYLATE FOR INJECTION not available?

The reason the manufacturer reported: Disruption of the manufacture of the drug.

When will DEFEROXAMINE MESYLATE FOR INJECTION be available again?

The manufacturer's estimated resolution date is November 23, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Check with your pharmacist
StatusShortage Avoided
Same-ingredient products on fileNone found
Affected strength2G
Report last updated2022-12-05
Checked by MedShort2026-11-13

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02247022

Strength

2G

Dosage Form

POWDER FOR SOLUTION

Route

SUBCUTANEOUS INTRAVENOUS INTRAPERITONEAL INTRAMUSCULAR

Active Ingredient

DEFEROXAMINE MESYLATE

Tier

Unrated

Last Updated

2022-12-05

Reason for Shortage

Disruption of the manufacture of the drug.

Past Reports for This Drug

DEFEROXAMINE MESYLATE FOR INJECTION has 2 shortage/discontinuation reports on file — this is one of them.